US Stock MarketDetailed Quotes

GRCE Grace Therapeutics

Watchlist
  • 3.230
  • -0.050-1.52%
Close Nov 21 16:00 ET
  • 3.230
  • 0.0000.00%
Post 20:01 ET
32.75MMarket Cap-3549P/E (TTM)

Grace Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Grace Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Grace Therapeutics Earnings Reports

  • Grace Therapeutics | 10-Q: Q2 2025 Earnings Report

    Nov 13 20:33

  • Acasti Pharma | 8-K: Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update

    Aug 9 20:02

  • Acasti Pharma | 10-Q: Q1 2025 Earnings Report

    Aug 9 19:32

  • Acasti Pharma | 10-K: FY2024 Annual Report

    Jun 21 19:36

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data